Nortiva Bio Launches Clinical-Stage Biopharmaceutical Company To Develop Long-Acting Oral Medicines
Benzinga Newsdesk 4 months ago
News
Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptiveCompany seeks pipeline expansion via industry
Company is advancing its proprietary LYNX™ drug delivery platform to develop oral therapies that last for up to a month, including a monthly oral contraceptive
Company seeks pipeline expansion via industry partnerships